https://www.research.vt.edu/impact-recognition/highly-cited-researchers.html
Highly Cited Researchers | Research and Innovation | Virginia Tech
Discover Virginia Tech's faculty recognized as Clarivate™ Highly Cited Researchers, reflecting their significant influence in various research fields.
highly cited researchersvirginia techinnovation
https://www.ece.uw.edu/spotlight/nathan-kutz-clarivate-2025/
Professor Nathan Kutz named to Clarivate’s Highly Cited Researchers list | UW Department of...
highly cited researchers listuw departmentprofessornathannamed
https://staff.sussex.ac.uk/news/article/66355-five-sussex-academics-among-world-s-most-highly-cited
Five Sussex academics among world’s most highly cited : Staff Hub : University of Sussex
The Clarivate Plc analytics company today (19 November) revealed its 2024 list of Highly Cited Researchers
highly citedstaff hubuniversity offivesussex
https://www.explorationpub.com/oep/index/58
Open Exploration Announces 2025 Highly Cited Paper Award and Best Young Researcher Paper Award
Open Exploration Announces 2025 Highly Cited Paper Award and Best Young Researcher Paper Award
open explorationhighly citedpaper awardbest youngannounces
https://cos.northeastern.edu/four-northeastern-researchers-named-to-2020-list-of-highly-cited-researchers/
Four Northeastern Researchers Named to 2020 List of 'Highly Cited Researchers' - Northeastern...
Jan 15, 2025 - Each year, the researchers most cited by their peers are recognized for their achievements in science. This year the College of Science has four faculty with...
highly citedfournortheasternresearchersnamed
https://www.tohoku.ac.jp/japanese/2025/11/award20251114-clarivate.html
Highly Cited Researchers ... | 受賞 | 東北大学 -TOHOKU UNIVERSITY-
クラリベイト・アナリティクスのHighly Cited Researchers 2025に、以下の本学関係者7名が選出されました。 Highly Cited Researchers(高被引用論文著者)...
highly cited researcherstohoku university
https://warwick.ac.uk/fac/sci/med/news/news/highlycited25/
Highly Cited Researchers at Warwick Medical School
Three Warwick Medical School academics have been named in Clarivate’s Highly Cited Researcher List 2025.
highly cited researchersmedical schoolwarwick
https://www.pnnl.gov/publications/thirteen-researchers-pacific-northwest-national-laboratory-among-worlds-most-highly
Thirteen Researchers from Pacific Northwest National Laboratory Among World’s Most Highly Cited |...
From developing new energy storage materials to revealing patterns of Earth’s complex systems, studies led by PNNL researchers are recognized for their...
pacific northwestnational laboratoryhighly citedthirteenresearchers
https://www.dana-farber.org/newsroom/news-releases/2019/dana-farber-cancer-institute-researchers-among-highly-cited-researchers-according-to-2019-web-of-science-group-list
Dana-Farber Cancer Institute researchers among highly cited researchers according to 2019 Web of...
23 Dana-Farber Cancer Institute Faculty listed on the 2019 Highly Cited Researchers list from Web of Science Group
dana farber cancer institutehighly citedaccording toresearchersamong
https://www.selleck.au/epigenetic-reader-domain.html
BET inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au
BET inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies.
bet inhibitorsmultiplepotenthighlyselective
https://www.selleck.au/c-Met.html
c-Met Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au
c-Met inhibitors (inhibiting targets of signalling pathways) used for various assays; some have entered clinical trials, which would be new cancer therapies.
cmetinhibitorsmultiplepotent
https://www.selleckchem.com/hdac-inhibitors-activators.html
HDAC Inhibitors | HDAC Activators: 90+Potent, Highly Selective & Cited | Selleckchem
HDAC inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
hdac inhibitorsactivatorspotenthighlyselective
https://www.selleck.co.uk/bcr-abl.html
Bcr-Abl inhibitors/activators | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
Bcr-Abl inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
bcr
https://www.selleck.au/bcr-abl.html
Bcr-Abl inhibitors/activators | Multiple potent, highly selective & well-cited | Selleck.Au
Bcr-Abl inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
bcrablinhibitorsactivatorsmultiple
https://www.selleckchem.com/p38-MAPK.html
p38 MAPK Inhibitors | p38 MAPK Activators: 50+Potent, Highly Selective & Cited | Selleckchem
p38 MAPK inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
p38 mapkinhibitorsactivatorspotenthighly
https://www.selleck.au/Ras.html
KRas inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au
K-Ras antagonist | K-Ras inhibitor | K-Ras agonist | K-Ras activator
kras inhibitorsmultiplepotenthighlyselective
https://www.selleck.au/mdm2.html
MDM2/MDMX Inhibitors/Antagonists | Multiple potent, highly selective & well-cited | Selleck.Au
MDM2/MDMX antagonist |MDM2/MDMX inhibitor |MDM2/MDMX agonist | MDM2/MDMX activator
mdm2inhibitorsantagonistsmultiplepotent
https://www.selleck.co.uk/mTOR.html
mTOR Inhibitors/Activators | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
mTOR inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
mtor inhibitorsactivatorsmultiple
https://www.selleckchem.com/ezh1_2.html
EZH2 Inhibitors: 20+Potent, Highly Selective & Cited | Selleckchem
EZH2 antagonist | EZH2 inhibitor | EZH2 agonist |EZH2 activator
ezh2 inhibitorspotenthighlyselectivecited
https://www.selleck.co.uk/PD-1-PD-L1.html
PD-1/PD-L1 | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
PD-1/PD-L1 inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer...
pdl1multiplepotenthighly
https://www.selleckchem.com/VEGFR-PDGFR.html
VEGFR Inhibitors: 100+Potent, Highly Selective & Cited | Selleckchem
VEGFR inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
vegfr inhibitorspotenthighlyselectivecited
https://www.selleck.co.uk/p53.html
p53 inhibitors/activators | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
p53 inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
p53inhibitorsactivatorsmultiple
https://www.selleck.au/EGFR(HER).html
EGFR Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au
EGFR inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
egfr inhibitorsmultiplepotenthighlyselective
https://news.ucsc.edu/2025/11/clarivate-2025/
UC Santa Cruz is the top public research university in the world for highly cited researchers amid...
Feb 27, 2026 - 25 UC Santa Cruz researchers earned a spot on the prestigious annual list.
uc santa cruzhighly cited researchers
https://www.selleck.co.uk/prmt.html
PRMT Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
prmt inhibitorsmultiplepotenthighly
https://www.selleck.co.uk/HIF.html
HIF Inhibitors/Modulators | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
HIF inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
hifinhibitorsmodulatorsmultiple
https://www.selleck.au/histone-methyltransferase.html
Histone Methyltransferase Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au
Histone methyltransferase inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies.
histoneinhibitorsmultiplepotenthighly
https://www.selleck.au/Akt.html
Akt Inhibitors/Activators | Multiple potent, highly selective & well-cited | Selleck.Au
Akt inhibitors (inhibiting targets of signalling pathways) used for various assays; some have entered clinical trials, which would be new cancer therapies.
akt inhibitorsactivatorsmultiplepotenthighly
https://www.selleckchem.com/ATM.html
ATM/ATR Inhibitors: 30+Potent, Highly Selective & Cited | Selleckchem
Our ATM/ATR inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies.
atmatrinhibitorspotenthighly
https://www.selleck.au/csf-1r.html
CSF-1R Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au
CSF-1R inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
csf1rinhibitorsmultiplepotent
https://www.selleckchem.com/pka.html
PKA Inhibitors | PKA Activators: 10+Potent, Highly Selective & Cited | Selleckchem
PKA inhibitors are available at Selleck. Check PKA signaling reviews and assay information.
pka inhibitorsactivatorspotenthighlyselective
https://www.selleck.co.uk/hydroxysteroid-dehydrogenase-hsd.html
Dehydrogenase Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
Dehydrogenase inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies.
dehydrogenase inhibitorsmultiplepotenthighlyselective
https://www.selleck.co.uk/ferroptosis.html
Ferroptosis Inhibitors/Inducers | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
Ferroptosis inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies.
ferroptosis inhibitorsmultiple
https://www.selleck.au/VEGFR-PDGFR.html
VEGFR Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au
VEGFR inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
vegfr inhibitorsmultiplepotenthighlyselective
https://www.selleckchem.com/Src-bcr-Abl.html
Src Inhibitors: 50+Potent, Highly Selective & Cited | Selleckchem
Src inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
src inhibitorspotenthighlyselectivecited
https://www.selleck.co.uk/PKC.html
PKC Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
Inhibitors targeting PKC are available at Selleck. Also check the Protein Kinase C pathway reviews and assay information
pkc inhibitorsmultiplepotenthighly
https://www.selleck.co.uk/csf-1r.html
CSF-1R Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
CSF-1R inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
csf
https://www.selleck.co.uk/nf-kb.html
NF-κB Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
Inhibitors on NF-kB signaling are available at Selleck. Check the NF-kappaB signaling reviews and assay information.
nfinhibitorsmultiplepotenthighly
https://www.selleck.au/PARP.html
PARP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au
PARP inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
parp inhibitorsmultiplepotenthighlyselective
https://www.selleck.co.uk/FGFR.html
FGFR Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
FGFR inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
fgfr inhibitorsmultiplepotenthighly
https://www.selleck.au/hdac-inhibitors-activators.html
HDAC Inhibitors/Activators | Multiple potent, highly selective & well-cited | Selleck.Au
HDAC inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
hdac inhibitorsactivatorsmultiplepotenthighly
https://www.prweb.com/releases/zocalo-health-receives-highly-competitive-path-cited-grant-by-california-department-of-health-care-services-302642015.html
Zócalo Health Receives Highly Competitive PATH CITED Grant by California Department of Health Care...
Dec 15, 2025 - /PRNewswire-PRWeb/ -- Zócalo Health, a community-based primary care provider dedicated to delivering culturally relevant care to underserved and...
department ofhealthreceiveshighly
https://www.selleck.co.uk/yap.html
YAP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
YAP antagonist | YAP inhibitor | YAP agonist | YAP activator
yap inhibitorsmultiplepotenthighly
https://www.selleck.co.uk/PARP.html
PARP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
PARP inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
parp inhibitorsmultiplepotenthighly
https://www.selleck.co.uk/HSP-90.html
HSP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
HSP (HSP90) inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer...
hsp inhibitorsmultiplepotenthighly
https://www.selleckchem.com/CDK.html
CDK Inhibitors: 140+Potent, Highly Selective & Cited | Selleckchem
CDK inhibitors (inhibiting targets of signaling pathways) used for various assays, some have entered clinical trials, which would be new cancer therapies.
cdk inhibitorspotenthighlyselectivecited
https://www.selleck.co.uk/histone-methyltransferase.html
Histone Methyltransferase Inhibitors | Multiple potent, highly selective & well-cited |...
Histone methyltransferase inhibitors used for various assays, some have entered clinical trials, which would be new cancer therapies.
histoneinhibitorsmultiplepotenthighly
https://www.selleck.co.uk/STING.html
STING Antagonist/Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
stingantagonistinhibitorsmultiple
https://www.selleck.au/HSP-90.html
HSP Inhibitors | Multiple potent, highly selective & well-cited | Selleck.Au
HSP (HSP90) inhibitors (inhibiting targets of signalling pathways) used for various assays, some have entered clinical trials, which would be new cancer...
hsp inhibitorsmultiplepotenthighlyselective
https://www.selleck.co.uk/Ras.html
KRas inhibitors | Multiple potent, highly selective & well-cited | Selleck.Co.Uk
K-Ras antagonist | K-Ras inhibitor | K-Ras agonist | K-Ras activator
kras inhibitorsmultiplepotenthighly